Rubius Therapeutics Inc (NASDAQ:RUBY)

10.00
Delayed Data
As of 3:59pm ET
 +0.52 / +5.49%
Today’s Change
3.35
Today|||52-Week Range
13.70
+31.75%
Year-to-Date
No recent news for Rubius Therapeutics Inc.

Today’s Trading

Previous close9.48
Today’s open9.55
Day’s range9.34 - 10.00
Volume16,002
Average volume (3 months)845,067
Market cap$767.2M
Data as of 3:59pm ET, 01/25/2021

Growth & Valuation

Earnings growth (last year)+8.51%
Earnings growth (this year)-1.25%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.77

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...+0.02+0.41%
VXRTVaxart Inc+2.92+40.90%
SYRSSyros Pharmaceutical...+0.04+0.33%
----
Data as of 6:22pm ET, 01/25/2021

Financials

Next reporting dateApril 1, 2021
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$0.00
Annual profit (last year)-$163.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts